27
Imke Steffen ZIB-Seminar 15. December 2008

Imke Steffen ZIB-Seminar 15. December 2008

Embed Size (px)

DESCRIPTION

Imke Steffen ZIB-Seminar 15. December 2008. Microbial “Anti-Immunology“. Highly effective mechanisms of pathogens to overcome both innate and acquired immunity - PowerPoint PPT Presentation

Citation preview

Page 1: Imke Steffen ZIB-Seminar 15. December 2008

Imke Steffen

ZIB-Seminar 15. December 2008

Page 2: Imke Steffen ZIB-Seminar 15. December 2008

Microbial “Anti-Immunology“

Highly effective mechanisms of pathogens to overcome both innate and acquired immunity

Difficulties in controlling these pathogens and developing vaccines (examples: HIV (virus), Tuberculosis (bacterium), Malaria (parasite))

Bacteria and viruses have developed a surprising number of parallel strategies and shared mechanistic concepts to neutralize host immunity

→ key concepts

Page 3: Imke Steffen ZIB-Seminar 15. December 2008

Bacteria and viruses use various mechanisms to overcome immunity

Finley, B. B. and McFadden, G., 2006

Page 4: Imke Steffen ZIB-Seminar 15. December 2008

Overview

Surface Expression and Secretion of Immune Modulators (examples: HIV gp120, bacterial secretion systems)

Avoiding Immune Surveillance (examples: interference with antigen presentation, GPCR signaling, antigenic variation)

Subversion of Immune Response Pathways (examples: Yersinia TTSS, complement inhibition)

Page 5: Imke Steffen ZIB-Seminar 15. December 2008

Surface Expression and Secretion of Immune Modulators

Finley, B. B. and McFadden, G., 2006

Page 6: Imke Steffen ZIB-Seminar 15. December 2008

Surface Expression and Secretion of Immune Modulators

The external surface of pathogens is the central interface between host and pathogen recognition microbial clearance

Pathogens can: present mimics of host immune modulators to alter or prevent immune

responses

express adhesins or receptor ligands to anchor the pathogen to the host surfaces

present invasins or fusion proteins to mediate uptake into host cells

Page 7: Imke Steffen ZIB-Seminar 15. December 2008

HIV virus can counterattack the CTL response through apoptosis

Petrovas, C. et al., 2005

(1) Resistance to CD95/Fas-mediated apoptosis in HIV-infected cells

(2) Upregulation of CD95L/FasL on the surface of infected cells (HIV nef)

(1) Chronic antigen-specific TCR activation

(2) Loss or lack of HIV-specific CD4+ T-cell help

(3) Aberrant or inappropriate chemokine receptor signaling

Page 8: Imke Steffen ZIB-Seminar 15. December 2008

Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system

Stanley, S. A. et al. 2003

The proteins Snm1, -2, and -4 are required for the secretion of ESAT-6 and CFP-10, small proteins previously identified as major T cell antigens

Snm4 mutants fail to limit both cytokine and effector responses early after infection of cultured macrophages and ultimately fail to replicate after phagocytosis

Page 9: Imke Steffen ZIB-Seminar 15. December 2008

Stanley, S. A. et al. 2003

Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system

Page 10: Imke Steffen ZIB-Seminar 15. December 2008

Avoiding Immune Surveillance

Finley, B. B. and McFadden, G., 2006

Page 11: Imke Steffen ZIB-Seminar 15. December 2008

Avoiding Immune Surveillance

Interference with Antigen Presentation

Hijacking of Chemokine Signaling

Bacterial and Viral Antigenic Variation

Page 12: Imke Steffen ZIB-Seminar 15. December 2008

MHC class I antigen presentation pathway and the common targets of viral immunoevasins

Ambagala, A. P. et al. 2005

The MHC class I HC and β2mare co-translationally translocated into the ER lumen

ER-resident chaperones (CNX, ERp57, CRT) facilitate properfolding

The MHC class I HC + β2m + CRT + ERp57 complex is bridged to TAP by tapasin, making the PLC

Peptides generated by the proteasome are translocated into the lumen of the ER by TAP

Peptide-loaded, stable MHCclass I molecules leave the ER, transit through the Golgi network and reach the cell surface

Page 13: Imke Steffen ZIB-Seminar 15. December 2008

The peptide-loading complex and viral proteins that exploit it

Lybarger, L. et al., 2005

Page 14: Imke Steffen ZIB-Seminar 15. December 2008

Viral pathogen hijacking of intracellular signalling networks is regulated by GPCRs

Sodhi, A. et al., 2004

(a) GPCR signaling upon chemokine binding, (b) viral glycoproteins might function as agonists or antagonists and use GPCRs as entry co-receptor, (c) / (d) viruses encode their own GPCR receptors or chemokines, (e) virally encoded chemokine binding proteins sequester cellular chemokines

Page 15: Imke Steffen ZIB-Seminar 15. December 2008

Blockade of chemokine activity by soluble vCKBPs from poxviruses and herpesviruses

Alcami, A., 2003

Page 16: Imke Steffen ZIB-Seminar 15. December 2008

Strategy used by poxvirus vIFN-α/βBP to block the biological activity of IFNs

Alcami, A., 2003

By covering the cells with decoy receptors, vaccinia virus creates an environment in which IFNs cannot induce a protective anti-viral response and prevent virus replication

Page 17: Imke Steffen ZIB-Seminar 15. December 2008

Role of KSHV-GPCR signalling pathways in Kaposi’s sarcomagenesis

Sodhi, A. et al., 2004

Page 18: Imke Steffen ZIB-Seminar 15. December 2008

Possible functions of virus-encoded chemokines and chemokine receptors

Alcami, A., 2003

Page 19: Imke Steffen ZIB-Seminar 15. December 2008

Lipid A modified by PagL and/or PagP in S. typhimurium show decreased ability to induce NF-B activation

Kawasaki, K et al., 2004

Page 20: Imke Steffen ZIB-Seminar 15. December 2008

Molecular mechanisms of HIV-1 genetic variation

Letvin, N. L., 2006

(a) The viral reverse transcriptase is

highly error prone, resulting in

each new virion encoding

approximately one new mutation

(b)When two HIV-1 virions with

different genetic sequences

enter the same cell, they can

both integrate and produce

viral RNA. Homologous

recombination or packaging

of RNA from different parent

viruses leads to the creation

of entirely new HIV-1

genomes

Page 21: Imke Steffen ZIB-Seminar 15. December 2008

Subversion of Immune Response Pathways

Finley, B. B. and McFadden, G., 2006

Page 22: Imke Steffen ZIB-Seminar 15. December 2008

Subversion of Immune Response Pathways

Bacterial Subversion of Innate Pathways

Bacterial and Viral Subversion of Phagocytes

Complement Inhibition by Viruses

Cell Death Manipulation

Page 23: Imke Steffen ZIB-Seminar 15. December 2008

The Yersinia effectors target multiple signaling pathways to inhibit host immune responses

Navarro, L. et al., 2005

Page 24: Imke Steffen ZIB-Seminar 15. December 2008

Myxoma Virus vCD200 Is Responsible for Down-Regulation of Macrophage Activation In Vivo

Cameron, C. M. et al., 2005

Page 25: Imke Steffen ZIB-Seminar 15. December 2008

Pathogens capturing C4BP are protected from complement-mediated lysis and phagocytosis

Blom, A.M., 2004

C4BP bound to the surface of a pathogen inhibits classical C3-convertase by accelerating its decay

C4BP serves as acofactor in cleavage of C4b both in solution and surface-bound, and C3b in solution

C4BP capture leadsto decrease in opsonization and less efficient phagocytosis

Page 26: Imke Steffen ZIB-Seminar 15. December 2008

Viral interactions with the BTLA/HVEM/LIGHT cosignaling pathway

Watts, T. H. and Gommerman, J. L., 2005

HSV gD binds to themembrane-distal CRD1 domain ofHVEMopposite the LIGHT-binding site and overlapping the binding siteof HVEM for BTLA

hCMV UL144 acts as a mimic of HVEM and binds to BTLA to send an inhibitory signal to T cells

Page 27: Imke Steffen ZIB-Seminar 15. December 2008

Concluding Remarks

Successful vertebrate pathogens must overcome or alter many effective host

defense mechanisms

Pathogens can serve as excellent tools to probe immune functions

Understanding the various Achilles heels of host defense helps to deconstruct

the fundamental properties of microbial pathogenesis

Studying the “anti-immune systems“ of pathogens is critical to contemplating

new therapies